Table 3.
Summary of management strategies of all pooled patients.
| Characteristics | Value |
|---|---|
| Surgery (n = 1307) | No. (%) |
| Biopsy | 87 (6.6%) |
| Surgical Resection | 1220 (93.3%) |
| Open | 1092 (89.5%) |
| Endoscopic | 111 (9.1%) |
| Combined (Open + Endo) | 17 (1.4%) |
| Extent of Surgical Resection (n = 776) | No. (%) |
| Gross Total Resection (100%) | 293 (37.8%) |
| Subtotal Resection (80–99%) | 355 (45.7%) |
| Partial Resection (<80%) | 128 (16.5%) |
| Surgical Approach (n = 521) | No. (%) |
| Endonasal Transsphenoidal | 111 (21.3%) |
| Frontotemporal Orbitozygomatic | 92 (17.6%) |
| Pterional | 62 (11.9%) |
| Infra-Temporal | 35 (6.7%) |
| Sub-Temporal | 32 (6.1%) |
| Trans-Petrosal | 32 (6.1%) |
| Retro-Sigmoid | 30 (5.8%) |
| Sub-Temporal + Infra-Temporal | 28 (5.4%) |
| Sub-Frontal/Bi-Frontal | 19 (3.6%) |
| Fronto-Temporal | 14 (2.7%) |
| Others | 61 (11.7%) |
| Conventional Photon-based Radiotherapy (n = 1307) | 421 (32.2%) |
| Median dose (Gy), range | 55, 6.5–70 |
| External Beam Radiation Therapy | 249 (59.1%) |
| Gamma Knife | 82 (19.5%) |
| Intensity Modulated Radiation Therapy | 40 (9.5%) |
| Linear Accelerator (LINAC) | 34 (8.1%) |
| Cyber Knife | 16 (3.8%) |
| Proton-based Radiotherapy (n = 1307) | 654 (50%) |
| Median dose (GyE), range | 70, 12–76 |
| Carbon-based Radiotherapy (n = 1307) | 133 (10.2%) |
| Median dose (GyE), range | 60, 57–69 |